Financials Xi'an International Medical Investment Company Limited

Equities

000516

CNE000000016

Healthcare Facilities & Services

End-of-day quote Shenzhen S.E. 06:00:00 2024-06-02 pm EDT 5-day change 1st Jan Change
5.5 CNY -3.51% Intraday chart for Xi'an International Medical Investment Company Limited -2.14% -32.18%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 9,352 24,236 25,019 27,755 18,275 12,393 - -
Enterprise Value (EV) 1 9,352 24,236 25,019 27,755 18,275 12,393 12,393 12,393
P/E ratio -23.1 x 629 x -29.8 x -23.5 x -50.7 x 50 x 24.3 x 28.9 x
Yield - - - - - - - -
Capitalization / Revenue 9.44 x 15.1 x 8.56 x 10.2 x 3.96 x 2.11 x 1.65 x 1.44 x
EV / Revenue 9.44 x 15.1 x 8.56 x 10.2 x 3.96 x 2.11 x 1.65 x 1.44 x
EV / EBITDA - 62 x -76.1 x -55.6 x 56.8 x 16.9 x 10.1 x 10.2 x
EV / FCF - - - - 56,288,269 x - - -
FCF Yield - - - - 0% - - -
Price to Book - 4.95 x 4.71 x 6.55 x 4.69 x 3.16 x 2.63 x 2.71 x
Nbr of stocks (in thousands) 1,928,232 1,928,108 2,268,265 2,267,593 2,253,340 2,253,340 - -
Reference price 2 4.850 12.57 11.03 12.24 8.110 5.500 5.500 5.500
Announcement Date 4/28/20 4/14/21 4/27/22 4/18/23 4/25/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 991 1,607 2,921 2,711 4,618 5,880 7,527 8,613
EBITDA 1 - 390.7 -328.7 -499.3 321.8 735 1,222 1,211
EBIT 1 - 7.87 -906.1 -1,133 -462 275.8 575.5 506
Operating Margin - 0.49% -31.02% -41.78% -10.01% 4.69% 7.65% 5.87%
Earnings before Tax (EBT) 1 - 7.352 -919.6 -1,140 -467.3 271.8 578.5 525
Net income 1 - 45.36 -822.2 -1,177 -368.4 249.1 516.1 438
Net margin - 2.82% -28.15% -43.4% -7.98% 4.24% 6.86% 5.09%
EPS 2 -0.2100 0.0200 -0.3700 -0.5200 -0.1600 0.1100 0.2267 0.1900
Free Cash Flow - - - - 324.7 - - -
FCF margin - - - - 7.03% - - -
FCF Conversion (EBITDA) - - - - 100.89% - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 4/28/20 4/14/21 4/27/22 4/18/23 4/25/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2024 Q1
Net sales 1 1,173
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 -104.9
Net margin -8.94%
EPS -
Dividend per Share -
Announcement Date 4/25/24
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - 325 - - -
ROE (net income / shareholders' equity) - 0.91% -15.9% -24.4% -9.03% 5.67% 10.5% 9.5%
ROA (Net income/ Total Assets) - - - -18.7% - 0.1% 1.8% 3.1%
Assets 1 - - - 6,307 - 249,135 28,671 14,129
Book Value Per Share 2 - 2.540 2.340 1.870 1.730 1.740 2.090 2.030
Cash Flow per Share 2 - 0.0200 0.2000 0.2000 0.4800 0.3700 1.190 -
Capex 1 - - - 1,091 763 213 213 213
Capex / Sales - - - 40.23% 16.52% 3.62% 2.83% 2.47%
Announcement Date 4/28/20 4/14/21 4/27/22 4/18/23 4/25/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5.5 CNY
Average target price
8 CNY
Spread / Average Target
+45.45%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 000516 Stock
  4. Financials Xi'an International Medical Investment Company Limited